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Abstract
The mechanisms underlying transthyretin-related amyloidosis
in vivo remain unclear. The abundance of the 49–127 transthyretin
fragment in ex vivo deposits suggests that a proteolytic cleavage
has a crucial role in destabilizing the tetramer and releasing the
highly amyloidogenic 49–127 truncated protomer. Here, we
investigate the mechanism of cleavage and release of the 49–127
fragment from the prototypic S52P variant, and we show that the
proteolysis/fibrillogenesis pathway is common to several amyloido-
genic variants of transthyretin and requires the action of
biomechanical forces provided by the shear stress of physiological
fluid flow. Crucially, the non-amyloidogenic and protective T119M
variant is neither cleaved nor generates fibrils under these
conditions. We propose that a mechano-enzymatic mechanism
mediates transthyretin amyloid fibrillogenesis in vivo. This may be
particularly important in the heart where shear stress is greatest;
indeed, the 49–127 transthyretin fragment is particularly abundant
in cardiac amyloid. Finally, we show that existing transthyretin
stabilizers, including tafamidis, inhibit proteolysis-mediated
transthyretin fibrillogenesis with different efficiency in different
variants; however, inhibition is complete only when both binding
sites are occupied.
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Introduction
The determinants of induction, anatomical distribution and rates of
progression of clinical transthyretin (TTR) amyloid deposition are
poorly understood. High-resolution 3D crystallographic structures of
native wild-type TTR and several amyloidogenic variants have iden-
tified no relevant features (Palaninathan, 2012), and the pathogenic
mechanism is probably hidden within the dynamics of folding and
subunit assembly. The native tetrameric assemblies of all amyloido-
genic TTR variants are less stable in vitro than those of wild-type
TTR, and the dissociated protomers have a strong propensity to self-
aggregate (Merlini & Bellotti, 2003), but there is no direct evidence
that this fully explains fibrillogenesis in vivo.
A key role for partial proteolysis in the initiation of amyloid fibril
formation in general has been debated extensively (Westermark
et al, 1996). The residue 49–127 C-terminal fragment is a major
component of ex vivo TTR amyloid fibrils (Thylen et al, 1993; Ihse
et al, 2013), regardless of the presence, nature or position of any
amyloidogenic mutation (Bergstrom et al, 2005). In particular, the
detection of this fragment in tissue biopsies correlates with amyloid
deposition in the heart (Ihse et al, 2013) and poor clinical prognosis
(Gustafsson et al, 2012).
The extremely rare S52P TTR variant is the least stable TTR vari-
ant and causes the most aggressive phenotype of hereditary
systemic TTR amyloidosis (Mangione et al, 2014). We have recently
shown that limited proteolysis of S52P TTR generates the 49–127
fragment that, if released under physiological fluid agitation, rapidly
self-aggregates into very stable aggregates (Mangione et al, 2014)
together with the full-length protein. The molecular mechanism of
this remarkable phenomenon and whether it underlies amyloid fib-
rillogenesis by other amyloidogenic TTR variants, including the
wild-type protein, are fundamental to understanding the pathogene-
sis of this amyloid disease.
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Results
Release of proteolytic fragments from the tetramer
Trypsin digestion of S52P TTR under physiological conditions (PBS,
pH 7.4, 37°C) without fluid agitation cleaves some but not all proto-
mers (Mangione et al, 2014) at residue Lys48. Under the mild shear
force conditions of low-pressure size-exclusion chromatography
(SEC), the cleaved protein eluted as a single peak with the same Ve
as native undigested tetrameric TTR (Fig 1A), and with both
full-length protomer and the truncated residue 49–127 fragment
detected by SDS–PAGE of the chromatographic peak (Fig 1A, inset).
The residue 1–48 TTR, which cannot be readily detected in our
electrophoretic system, was confirmed by non-native MS of the SEC
fraction (Fig 1B). The cleaved protein thus remained exclusively in
the native tetrameric assembly. Similarly in non-denaturing MS
(native MS) with low acceleration voltage, only complete native
mass tetramers were observed in the trypsin-digested protein.
Despite the expectation that both intact tetramers and tetramers
with at least one cleaved protomer would be present, there was no
evidence for either truncated tetramers, having lost fragments 1–48
or 49–127, or the fragments themselves (Fig 2A).
To release the peptide in the gas phase, we mass-selected the
13+ charge state of the tetramer(s) and increased the acceleration
voltage. Both the 1–48 and 49–127 fragments were visible in the low
m/z region of the resulting mass spectrum, together with a stripped
trimer at high m/z. With further increases in accelerating voltage,
the intact tetramers released full-length protomers which progres-
sively overwhelmed the signal arising from the fragments (Fig 2A–E).
The generation of a truncated tetramer at higher energy, containing
three intact protomers and the fragment 49–127, strongly suggests
that the fragment 1–48 is the first to be released (Fig 2F). The
release of these fragments, at lower energy than the full-length
protomers, indicates that the cleavage has destabilized the truncated
protomer.
Single proteolytic cleavage destabilizes the tetramer
We compared the stability of the different full-length protomers
and/or proteolytic fragments as described before (Keetch et al,
2005; Hyung et al, 2010), by selecting charge states and activation
in the gas phase. We observed that after proteolysis of S52P TTR,
the tetramers were less stable (Appendix Fig S1A, blue versus red
line). Moreover, the fragments were released at lower acceleration
voltages than the full-length subunits (Appendix Fig S1B, dotted
versus dashed lines). The difference observed here would be even
more dramatic if each tetramer contained at least one cleaved
protomer. As expected, the non-cleaved subunits showed similar
dissociation patterns, irrespective of whether or not the protein
had been incubated with trypsin (Appendix Fig S1B, blue and red
dashed lines). A similar experiment was performed on wild-type
TTR, which is resistant to limited proteolysis in the absence of
fluid stirring (Mangione et al, 2014). The dissociation pattern
(Appendix Fig S1, green lines) was similar to that of the
non-cleaved S52P variant TTR indicating a similar overall stability
of the two tetramers.
Molecular dynamics simulation
In order to study the effect of proteolytic cleavage, we undertook
molecular dynamics (MD) simulations for wild-type TTR and the
S52P variant, both with and without cleavage at residue Lys48. As
residue 48 is located far from the two different dimer interfaces, the
four subunits were considered as independent and cleavage was
performed on each protomer, in order to increase sampling. Simula-
tions were optimized to reproduce physiological conditions as far as
possible (see Materials and Methods). During the first 500 ns, wild-
type and S52P TTR maintained folded structures closely resembling
their native crystal structure (Mangione et al, 2014) with no appar-
ent unfolding (Fig 3A). Following cleavage at Lys48, MD simula-
tions of S52P TTR revealed a dramatic unfolding of the 43–48 strand
A B
Figure 1. Fragments are retained within the tetramer after limited proteolysis.
A Size-exclusion chromatography elution profile of S52P TTR after limited proteolysis shows a single peak eluting at the same retention volume (14.3 ml) as TTR
tetramer. Inset, SDS–15% PAGE analysis confirms that the tetramer eluting in the peak is partially cleaved. Lane i: marker proteins (14.4, 20.1, 30.0, 45.0, 66.0 and
97.0 kDa); lane ii: S52P TTR after limited proteolysis; lane iii: SEC eluted peak. Arrows show the full-length protomer (residues 1–127) and the tryptic 49–127 fragment.
B Mass spectrum of SEC eluted peak of trypsin-digested S52P TTR. The sample was partially denatured by twofold dilution in 25% acetonitrile and 0.05% formic acid,
showing the presence of full-length protomer (purple) and both 1–48 (blue) and 49–127 (red) fragments.
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Figure 2. Following limited proteolysis, truncated fragments and full-length protomer are released from the tetramer at increasing energy.
A Mass spectrum of native S52P TTR (green) obtained at low collision energy. The red box highlights the 13+ charge state precursor.
B The 13+ charge state was then selected and subjected to increasing collision energy.
C–E The cleaved fragments 1–48 (blue) and 49–127 (red) were released from the tetramer before dissociation of the full-length protomer (purple). The adducts visible
on the tetramer were identified as the tryptic peptide CPLMVK (Appendix Figs S6 and S7). Double arrows indicate the m/z ranges where signal intensity was
magnified fivefold.
F Scheme showing the release of cleaved fragments and full-length protomer obtained by collision-induced dissociation (CID) after limited proteolysis. The
experimental molecular masses of the different complexes in (A–E) are in good agreement with the theoretical values in (F); the small difference(s) arise from
incomplete desolvation and the inherent measurement error of the method.
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accompanied by the allosteric loss of the EF-helix (Fig 3B and C;
Movie EV1). This observation enables us to rationalize our MS
results, in which the 1–48 fragment was released from the cleaved
tetramer prior to the 49–127 polypeptide, since MD simulation
shows that the latter remains engaged in inter-subunit contacts.
The effect of cleavage on hybrid tetramers of wild-type/S52P TTR
The exchange of protomers between tetramers of TTR has been
described previously (Keetch et al, 2005; Hyung et al, 2010), and
certain point mutations known to destabilize the tetramer (e.g. L55P
TTR) have been shown to enhance the rate of subunit exchange
between tetramers (Keetch et al, 2005). We reasoned that increased
subunit exchange rates could also occur in S52P TTR following
trypsin cleavage, given the reduced stability of the tetramer. To
explore this hypothesis, we first incubated wild-type TTR with
isotopically labelled (13C15N) S52P TTR for 72 h. The resulting mass
spectrum revealed different populations of tetramers containing the
following: 4L, 3L1H, 2L2H, 1L3H and 4H subunits corresponding to
L: light wild-type TTR, and H: heavy S52P TTR (Fig 4A). After
3 days, subunit exchange reached equilibrium with statistical distri-
bution of subunits among the heterotetramers confirming that
subunit exchange was complete.
We followed the kinetics of subunit exchange between wild-type
TTR and the S52P variant and plotted the relative abundance of
each tetrameric population with time (Fig 4B, black lines). Simi-
larly, in a second experiment we monitored the kinetics of exchange
of S52P TTR protomers alone using labelled and unlabelled protein
(Fig 4B, green lines). We then compared the exchange kinetics
of wild-type and (13C15N) S52P TTR with that of labelled and
unlabelled S52P TTR. We found that subunit exchange was notably
faster for S52P TTR alone suggesting a more dynamic state for pure
S52P TTR than for the S52P/wild-type hybrid TTR.
In a third experiment, we performed limited proteolysis with
trypsin on wild-type and labelled S52P TTR protomers which had
pre-equilibrated for 3 days to form hybrid tetramers (Fig 4C). The
mass spectrum recorded for the proteolysed tetramers (Fig 4C,
lower) was indistinguishable from that of the fully exchanged non-
proteolysed tetramers (Fig 4A). By performing tandem MS, we were
able to isolate and activate each of the different tetramers. This
enabled us to release the proteolytic fragment if formed. Activation
of the isolated 4L species (Fig 4C, top) confirmed that it contained
only full-length wild-type subunits. Similarly, the 4H species was
found to contain a mixture of both protomers and fragments of S52P
TTR. Interestingly, we were able to release fragments from all
hybrid tetramers containing at least one S52P TTR protomer. More-
over, the intensity of the fragments increased with the number of
S52P TTR subunits within the tetramer. Under these proteolysis
conditions, in which the amount of variant protomers was kept
identical in both hybrid and homotetrameric S52P TTR (Fig 4D),
wild-type subunits were not cleaved, confirming the resistance to
trypsin digestion of wild-type TTR in this state (see Materials and
Methods) and demonstrating that S52P variant TTR is more suscep-
tible to proteolysis.
A B
C
Figure 3. Cleavage at residue Lys48 induces an allosteric conformational change.
A Structures of wild-type and S52P subunits after 500-ns MD simulation are similar to the original wild-type crystal structure (Mangione et al, 2014). Conversely, the
cleavage of S52P TTR induces an unfolding in the 43–48 strand, followed by loss of secondary structure in the Ser23, Glu54 regions and the EF-helix (in blue),
respectively.
B Relative percentage of secondary structure retained during the simulations of wild-type (black) and of the S52P variant TTR with (red) and without (blue) cleavage.
The solid lines show average values measured in four independent subunits. The full colour areas represent standard deviations.
C Root mean square deviations during the simulations of wild-type (black) and S52P variant TTR before (blue) and after (red) cleavage.
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The effect of increased shear stress on the cleavage of
TTR variants
Based on the 3D structure of S52P TTR (PDB 4MRC), we hypothe-
sized that its susceptibility to proteolytic cleavage depends on the
high flexibility of the single peptide bond within the loop between
strands C-D in the variant (Mangione et al, 2014). It is possible that
fluid stirring could expose TTR to forces that enhance the flexibility
of the C-D loop. We investigated this idea with five naturally
occurring disease-associated variants and monitored aggregation
A
C D
B
Figure 4. S52P/wild-type hybrid TTR: formation, proteolysis, fragment release and fibril formation.
A Subunit exchange experiments between light recombinant wild-type (L, blue) and heavy (13C15N) S52P TTR (H, red) showing that both proteins can exchange subunits.
B Comparison of exchange between light recombinant wild-type/heavy S52P TTR (black lines) and light S52P/heavy S52P TTR (green lines) shows that dynamics are
faster when only S52P TTR is present. Light subunit, blue; heavy subunit, red.
C Subunit exchange between light wild-type (blue) and heavy S52P TTR (red) followed by limited proteolysis. All species were isolated and dissociated (MSMS) to yield
1–48 and 49–127 fragments (green and red stars, respectively) that can be detected from any of the intermediate species containing at least one monomer of heavy
S52P TTR. The presence of traces of S52P TTR in the wild-type TTR spectrum (top) and vice versa (bottom) is due to partial overlap of the different molecular ion
species during selection. The lowest spectrum corresponds to the full-scan MS spectrum showing all the species.
D Normalized thioflavin T (ThT) fluorescence data of homotetrameric S52P (9 lM, black) and homotetrameric wild-type TTR (9 lM, blue); hybrid TTR (wild-type
TTR, 9 lM + S52P TTR, 9 lM) before (green) and after (red) 72-h subunit exchange, respectively. Data plotted as mean  SD of at least three replicates.
Inset, SDS–15% PAGE under reducing conditions of wild-type/S52P hybrid TTR (i) and S52P TTR (ii) after 5-h incubation with trypsin at 37°C. Marker proteins
(14.4, 20.1, 30.0, 45.0, 66.0 and 97.0 kDa) are included. Arrows indicate the full-length protomer (residues 1–127) and the tryptic 49–127 fragment,
respectively.
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(Fig 5A) in the presence of trypsin under fluid stirring and the larger
air/water interface of 1.5 cm2 of a glass vial rather than 0.2 cm2 of
a microtitre well. We found that, in these conditions, wild-type and
four of the variants became susceptible to trypsin cleavage. SDS–
PAGE confirmed that the 49–127 C-terminal fragment was released
from the proteolysed tetramer in each case (Fig 5B). We then tested
the solutions for the presence of fibrils and found that, after 72 h,
genuine amyloid fibrils had formed when proteolysis had occurred
(Fig 5). The pathognomonic amyloid apple-green birefringence
under polarized light after Congo red staining (Fig 5C) and the typi-
cal fibrillar structure (Fig 5D) were observed in all those samples. A
sixth variant, the non-amyloidogenic T119M TTR, was resistant to
proteolysis and did not form fibrils.
SDS–PAGE analysis of the fibrillar material confirmed that, in all
the amyloidogenic variants and the wild-type, the main component
was the residue 49–127 polypeptide together with a minor band of
uncleaved monomer (Appendix Fig S2). The increase in the concen-
tration of the fragment in solution and the consumption of the
protomer were not correlated, probably because of a combination of
two different influences on the TTR fragment once it was released
from the tetramer. The truncated polypeptide is most likely largely
unfolded and can undergo two competing reactions: either being
A
B
C
D
Figure 5. Effect of trypsin on amyloidogenesis of S52P, L55P, V122I, V30M, WT and T119M variant TTR.
A Aggregation was quantified as spectrophotometric turbidity at 400 nm of samples incubated in PBS pH 7.4 at 37°C for 72 h with magnetic bar agitation in the
absence (open bars) or presence (solid bars) of trypsin at an enzyme:substrate ratio of 1:200. Each bar shows mean  SD of three replicates.
B Selective proteolytic cleavage of TTR was monitored by SDS–PAGE under reducing conditions, stained with Coomassie Blue. Quantification of each electrophoretic
band is shown in Appendix Fig S3.
C Amyloid was identified by light microscopy of Congo red-stained specimens viewed under crossed polarized light (scale bar, 10 lM).
D Negatively stained transmission electron microscopy (TEM) (scale bar, 100 nm) of TTR samples treated with trypsin as described above.
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further digested by the protease or accumulated into fibrillar aggre-
gates. Susceptibility to the proteolytic cleavage was therefore more
reliably monitored by consumption of the intact protomer than direct
estimation of the cleavage product in the trypsin-treated samples as
shown in Figure 5B. S52P TTR was substantially more susceptible to
proteolytic cleavage than wild-type TTR, and only T119M TTR was
totally resistant to digestion (Appendix Fig S3A). Under the effect of
agitation alone and in the absence of trypsin, none of the proteins
were cleaved and maintained their solubility (Appendix Fig S3B).
TTR ligands can prevent mechano-enzymatic cleavage
We previously reported that thyroxine binding by S52P TTR does
not prevent trypsin cleavage of this variant and its consequent fibril
formation, suggesting that small ligands may have only marginal
effects on this proteolysis-primed pathway of TTR amyloidogenesis
(Mangione et al, 2014). Here, we investigated the effect of two small
stabilizing ligands, tafamidis (Coelho et al, 2013) and diflunisal
(Berk et al, 2013), which are currently being trialled for the treat-
ment of TTR amyloidosis. Protein/ligand complexes were subjected
to our established fibrillogenesis assay in which the thioflavin
T signal is monitored before and after the addition of trypsin with
agitation and compared with the aggregation of the protein alone
(see Materials and Methods). Consistent with the lack of efficacy of
thyroxine, neither tafamidis nor diflunisal, even in large molar
excess over TTR, inhibited the proteolytically mediated fibrillogenesis
of S52P TTR (Appendix Fig S4).
Since susceptibility to proteolysis correlates with protein
stability, it is possible that cleavage and dissociation of the very
unstable S52P TTR variant was too rapid to be inhibited by TTR
ligands. In contrast, V122I TTR, the most prevalent TTR variant
causing cardiac amyloidosis and with its clinical role currently
under extensive investigation (Quarta et al, 2015), has stability and
susceptibility to cleavage intermediate between S52P and wild-type
TTR. We therefore monitored the effects of two monovalent TTR
stabilizers, tafamidis (Bulawa et al, 2012) and diflunisal (Berk et al,
2013), and the experimental palindromic compound mds84 (Kolstoe
et al, 2010), on fibrillogenesis of V122I under conditions suitable for
enzymatic cleavage and formation of fibrils. At 96 h, when fibrils
were formed in the absence of any ligand, we measured the intensities
of the full-length protomer electrophoretic bands and the turbidity
at 400 nm in the presence and absence of the ligands. The different
ligands inhibited both proteolysis and aggregation with varying
levels of potency (Fig 6), the palindromic mds84 (Kolstoe et al,
2010) being the most effective, followed by diflunisal and tafamidis
(Berk et al, 2013; Coelho et al, 2013).
Discussion
S52P TTR variant provides a unique model for elucidation of the
pathway of TTR amyloidogenesis primed by proteolytic cleavage
of the 48–49 peptide bond. In circulating plasma of carriers
heterozygous for this TTR mutation, wild-type/S52P TTR hybrid
tetramers will be present (Schneider et al, 2001). We therefore anal-
ysed both homotetrameric S52P TTR and hybrid tetramers and
observed selective proteolytic cleavage of S52P TTR followed by
release of truncated polypeptides. Importantly, the fragments
remained associated within the tetramer and were only released
upon activation, either in the gas phase or following shear stress.
Crucially, fibril formation is then triggered only by the release of the
fragments.
Molecular dynamics simulations suggest that after proteolysis,
the tetramer experiences a loss of secondary structure and becomes
unstable. Our mass spectrometry results show that release of the
cleaved 1–48 and 49–127 fragments, and of the full-length protomer,
occurred sequentially with increasing activation energy. The experi-
mental mass spectrometry observations are therefore completely
consistent with our MD simulations both demonstrating that the
1–48 fragment is the first to be released, evidently since it partici-
pates in fewer subunit interactions.
The in vivo circumstances of TTR cleavage and subsequent
fibril formation are of considerable interest. Amyloid deposits
formed in vivo by the majority of TTR variants contain the
truncated 49–127 polypeptide (Ihse et al, 2013), but the identity
and location of the protease responsible for the pathogenic cleav-
age are not known. We show here that cleavage can remain
hidden within fully assembled, native S52P TTR tetramers and it is
possible that proteolytic cleavage and tetramer disassembly may
occur in vivo in different tissues and/or in different compartments
of the same tissue.
Although some amyloidogenic TTR variants were apparently
resistant to proteolysis (Mangione et al, 2014), we have shown
here that susceptibility to proteolytic cleavage is enhanced by
increasing shear stress. The amyloidogenic variants L55P, V122I,
V30M and wild-type TTR, which itself is amyloidogenic in senile
TTR amyloidosis, become susceptible to proteolytic cleavage and
disassembly of the truncated protomer under increasing shear
stress. Only the non-pathogenic T119M TTR variant, expression of
which actually protects carriers of amyloidogenic mutations from
developing amyloidosis (Hammarstrom et al, 2003), is resistant to
proteolysis and fibrillogenesis. Based on our previous experiments
(Mangione et al, 2013), we calculated that the shear and
hydrophobic forces acting on TTR molecules under our fibrillogen-
esis conditions range from 5 to 100 pN. Such force is most likely
sufficient to perturb the structure of the native protein (Cecconi
et al, 2005; Borgia et al, 2008) exposing the C-D loop for prote-
olytic cleavage in all TTR variants examined with the exception of
T119M.
The physiological relevance of protein activation by biomechani-
cal forces is well established in the metabolism of von Willebrand
factor (Zhang et al, 2009), a multimeric assembly in which cleavage
of the A2 domain by the metalloprotease ADAMTS13 occurs only
under fluid shear stress. In the case of TTR, it is not known whether
the mechano-enzymatic processing of the protein affects normal
catabolism of the protein or only contributes to amyloid formation.
In the latter case, clinical and biochemical observations suggest that
the genesis of the truncated peptide and its deposition could deter-
mine the natural history and prognosis (Gustafsson et al, 2012) of
the disease. Indeed, we propose here that proteolytic cleavage
enabled by sufficient biomechanical forces may importantly influ-
ence the tissue specificity of TTR amyloid deposition. Shear and
interfacial forces generated by fluid flow (Stoppini & Bellotti, 2015)
are particularly high in certain organs, especially in the heart where
TTR amyloid is commonly deposited. The contribution of hydropho-
bic forces generated by extracellular ubiquitous macromolecules,
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which are crucially involved in the amyloid deposition (Bellotti &
Chiti, 2008), is unclear. Data on the intensity of shear stress in the
heart in vivo are difficult to obtain; however, Dokos and collabora-
tors show that the shear forces generated in conditions mimicking
those present in the ventricular myocardium are similar or even
stronger (Dokos et al, 2000, 2002) to those used in our experimental
conditions. Squeeze flow, as occurs in the heart, could further
contribute to protein deformation, as observed with various types of
polymers (Rowland et al, 2008). Also, TTR variants differ in stabil-
ity and susceptibility to proteolytic cleavage. Thus, S52P TTR is
readily cleaved under static conditions but requires shear stress
forces for dissociation of the cleaved protomers, while wild-type
TTR is cleaved only when exposed to stronger shear forces than
those sufficient to dissociate the truncated subunit(s) from the
tetramer.
These findings combine to provide a compelling mechanism that
is consistent with the propensity for TTR amyloid deposition in the
heart (Fig 7). In this model, TTR variants that are very sensitive to
selective proteolytic cleavage, such as S52P TTR, circulate as tetra-
mers, even if the 48–49 peptide bond is cleaved in one protomer.
We hypothesize that, during transit through the heart, the strong
local shear and interfacial forces cause release of the cleaved
49–127 peptide which is then rapidly incorporated into amyloid
fibrils. Alternatively, cleavage and dissociation could occur simulta-
neously, in the same anatomical site, in which both strong shear
stress and the relevant proteolytic enzyme are present (Fig 7). The
mechano-enzymatic mechanism that we have identified here for
TTR may also contribute significantly to amyloid formation by other
proteins in which proteolytic cleavage enabled by shear stress
in vivo could promote fibrillogenesis, since highly amyloidogenic
truncated forms of the soluble precursors have been found in
amyloid fibrils derived from monoclonal immunoglobulin light
chains, serum amyloid A protein, b2-microglobulin and apolipopro-
tein AI (Merlini & Bellotti, 2003). The mechanism of proteolysis-
mediated TTR amyloidogenesis will be validated in transgenic mice
expressing S52P TTR variant. To reproduce experimentally the
in vivo conditions, a better understanding of the shear stress
occurring at the interstitial space in the human heart will also be
crucial.
The new pathway of TTR amyloidogenesis, which we have now
characterized in vitro, may have important implications for drug
development, including the tetramer stabilizing drugs currently in
clinical trials. These agents were designed or selected to inhibit only
one step in the fibrillogenesis pathway, as the key role of proteoly-
sis has not previously been recognized and inhibitory effects
thereon have not yet been considered (Connelly et al, 2010). For
example, ligand-mediated inhibition of the mechano-enzymatic
pathway of amyloidogenesis may be different for each variant.
We have preliminary data showing that tafamidis may inhibit
V30M TTR fibrillogenesis (Appendix Fig S5) at a lower dose
(IC50 = 6 lM  1.4) than the one required for V122I TTR
(9 lM  0.7, Fig 6). Elucidation of the new pathway should also
refocus drug discovery efforts towards molecules able to inhibit fib-
rillogenesis by inducing stabilization and protection of the preferen-
tial proteolytic sites. Furthermore, simultaneous occupancy of the
two thyroxine binding pockets, such as the one achieved by the
prototypic palindromic ligand, mds84 (Kolstoe et al, 2010), would
overcome the problem of negative cooperativity of binding of the
A
B
C
Figure 6. Proteolysis and fibrillogenesis of V122I TTR in the presence of
TTR stabilizing drugs.
A–C Aggregation of 18 lM V122I TTR was monitored by turbidity at 400 nm
after addition of trypsin in the presence of 0, 9, 18, 36 and 72 lM of (A)
tafamidis, (B) diflunisal and (C) mds84, respectively, for 96 h; aliquots of
each sample were analysed by SDS–15% PAGE under reducing
conditions. Values of turbidity (black line) at 400 nm were normalized to
100% for aggregation of the protein alone. Intensities of the SDS–PAGE
band corresponding to the intact protomer in the whole mixture (blue
line) were normalized to 100% for the same band of the protein before
addition of trypsin. The solid lines represent the nonlinear fit to the
experimental data. IC50 values for TTR aggregation curves and
corresponding ligand structures are included. All data shown represent
mean  SD of three independent experiments.
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existing drugs and should improve protection against amyloido-
genic misfolding of TTR.
Materials and Methods
Preparation of recombinant proteins
Recombinant wild-type and S52P TTR were expressed and purified
as previously described (Lashuel et al, 1998). Isotopically double-
labelled proteins were expressed using Spectra 9 minimal medium
(13C, 98%; and 15N, 98%) (Cambridge Isotope Laboratories, Inc.).
Hybrid wild-type/S52P TTR was prepared with equimolar mixtures
of 9 lM homotetramer wild-type and S52P TTR left at 4°C for 72 h
allowing the subunit exchange to reach the equilibrium (Keetch
et al, 2005). All chemicals were purchased from Sigma (Poole,
Dorset, UK) unless otherwise stated.
Size-exclusion chromatography
Size-exclusion chromatography of S52P TTR after digestion with
trypsin (5 ng/ll) (Promega Trypsin Gold Mass Spectrometry Grade)
was performed using a Superdex 200 column on the A¨KTA Explorer
apparatus (GE Healthcare). The column was equilibrated and eluted
at 0.5 ml/min with phosphate-buffered saline, pH 7.4 (PBS). The
eluted peak was analysed by SDS–homogeneous 15% PAGE (GE
Healthcare) under reducing conditions and mass spectrometry
analysis after sample denaturation with 25% acetonitrile and 0.05%
formic acid.
Native mass spectrometry
After limited proteolysis, TTR aliquots were buffer-exchanged with
200 mM ammonium acetate pH 7.4 using Micro Bio-Spin size-
exclusion chromatography columns (Bio-Rad) and loaded into
in-house prepared glass capillaries for nano-electrospray (Hernandez
& Robinson, 2007).
Energy ramping experiments were performed on a Q-TOFII modi-
fied for the transmission of large complexes (Sobott et al, 2002) and
a synaptG2 (Waters). Parameters were as follows: capillary, cone
and transfer voltages were set to 1.3 kV, 80 and 5 V, respectively.
The acceleration voltage in the collision cell was ramped from 20 to
70 V with 2 to 10 V increments. The backing pressure in the trans-
fer region was set to 5 mbar. To follow kinetics of subunit
exchange, light and heavy proteins were first buffer-exchanged and
then equal amounts were incubated for 3 days. Aliquots were
regularly analysed on a TOF instrument (LCT; Waters) with the
following parameters: 1.1 kV and 50 V of the capillary and sample
cone voltages, respectively, and 5 mbar of backing pressure. To
investigate the dissociation of cleaved S52P TTR after complete
Figure 7. Amyloidogenesis of TTR primed by limited proteolysis in vivo.
Scheme of the sequential events which, in vivo, may occur after specific cleavage of TTR, as exemplified by of the S52P variant, with release of the truncated species
and full-length protomers (open arrows) in the heart where shear and interfacial forces are the highest. Alternatively, the forces required to cleave other
amyloidogenic variants including wild-type TTR (solid arrows) may enable the release of both the 49–127 fragment and the full-length protomer which can then
aggregate into fibrils.
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subunit exchange with the wild-type isoform, equimolar mixtures of
50 lM light wild-type and heavy S52P TTR were incubated in PBS
for 3 days at 4°C and then overnight with trypsin at 37°C. The
resulting sample was then buffer-exchanged, and analysed on a
Q-TOFII (Waters) with the same parameters as described above,
except for the acceleration voltage in the collision cell set to 40 V
for an optimal visualization of the fragments. Calibration was
performed using caesium iodide at 100 mg/ml, and mass spectra
were analysed with MassLynx V4.1.
Molecular dynamics simulations
Three simulations were prepared: native tetrameric wild-type TTR
and both native and Lys48-cleaved S52P variant TTR. As residue
48 is located far from the two different dimer interfaces, the four
subunits were considered as independent and cleavage was
performed on each protomer, in order to increase sampling. Avail-
able crystal structures only include a dimer (Mangione et al, 2014),
and inclusion of symmetry mates within the crystal led to the
creation of a tetrameric arrangement. Cleavage of all four TTR
monomers in S52P tetramer was reproduced by inserting COO
and NH3
+ termini between residues Lys48 and Thr49. Based on
their neighbourhood, in all systems histidine amino acids were
e-protonated. All systems were solvated in a box of TIP3P water,
and neutralized with the addition of 0.15 M Na+ and Cl ions.
Final systems had a size of approximately 60,000 atoms. Molecular
dynamics simulations were performed using the Amber99SB
(Hornak et al, 2006) force field on NAMD2.9 molecular dynamics
engine (Phillips et al, 2005) with SHAKE algorithm constraining
heavy-atom distances, and PME treating the electrostatic interac-
tions in periodic boundary conditions. All the systems were first
minimized with 2,000 conjugate gradient steps, and subsequently
simulated using a 2 fs timestep. Systems were first equilibrated in
the nPT ensemble for 0.5 ns, with a 10 kcal/mol constrain on
protein alpha carbons. 300 K and 1 Atm were imposed by
Langevin dynamics, using a damping constant of 1/ps, a piston
period of 200 fs and a piston decay of 50 fs. Constraints were
subsequently removed, and systems were simulated in the nVT
ensemble at 300 K for 1 ns. Finally, production runs for wild-type,
S52P and S52P cleaved systems were run in the nPT ensemble
(300 K and 1 Atm) for 522, 523 and 679 ns, respectively. From
every production simulation, one structure per nanosecond was
finally extracted and its secondary structure content assigned using
STRIDE as implemented in VMD’s timeline tool (Humphrey et al,
1996). The percentage of conserved secondary structure elements
in each subunit was computed by comparing any frame to the first
one. Movie and rendering of protein structures have been produced
with VMD.
Fibrillogenesis of hybrid tetramers
Samples of 100 ll recombinant wild-type/S52P TTR before and
after the completion of subunit exchange, prepared as described
above, were incubated in PBS pH 7.4 containing 10 lM thioflavin
T (ThT) (Mangione et al, 2014) at 37°C in Costar 96-well
black-wall plates sealed with sealing films. Homotetramer
wild-type and S52P TTR at 9 lM, respectively, were analysed in
the same plate and subjected to 900-rpm double-orbital shaking
(BMG LABTECH FLUOstar Omega), and bottom fluorescence was
recorded as previously described (Mangione et al, 2014). After
1 h, 5 ng/ll trypsin or buffer alone was added and fluorescence
was monitored in three or more replicates and control wells for
the next 5 h. Fibrillar material was analysed by SDS–homogeneous
15% PAGE under reducing conditions. The effect of both tafamidis
(Bulawa et al, 2012) and diflunisal (Berk et al, 2013) on fibrilloge-
nesis of homotetramer S52P TTR (18 lM) was explored after
incubating each protein sample at 37°C for 30 min in the presence
of ligands at one-, two-, five-, eight- and tenfold molar excess,
respectively. Protein/ligand complexes were then placed into
96-well black-wall plates and the fibrillogenesis procedure was
carried out as described above. After the addition of trypsin to
each well, ThT fluorescence was monitored for at least 10 h. The
data were normalized to the signal plateau at 10 h after the
initiation of each reaction.
Cleavage and fibrillogenesis of other amyloidogenic TTR variants
and wild-type TTR
Fibrillogenesis of L55P, V122I, V30M, and wild-type alongside S52P
and the non-amyloidogenic T119M TTR variant was carried out in
glass vials stirred at 1,500 rpm (IKA magnetic stirrer) and 37°C
using 18 lM TTR in PBS pH 7.4 in the presence and in the absence
of trypsin (5 ng/ll). The glass vial had an air/water interface of
1.5 cm2. Turbidity at 400 nm was monitored over time until it
reached a plateau (72 h). Samples were analysed by SDS–homoge-
neous 15% PAGE (GE Healthcare) under reducing conditions, and
bands corresponding to the intact TTR protomer were quantified
with Quantity One software (Bio-Rad). After staining with alcoholic
acid Congo red (CR), aggregated material was observed with polar-
ized light microscopy. Morphology of wild-type TTR aggregates was
characterized by electron microscopy as previously described (Man-
gione et al, 2014). Fibrillogenesis of V122I TTR was monitored by
light scattering at 400 nm in the presence and the absence of 0.5-,
one-, two- and fourfold molar excess of tafamidis (Bulawa et al,
2012), diflunisal (Berk et al, 2013) and mds84 (Kolstoe et al, 2010).
The effect of tafamidis on V30M TTR fibril formation was also moni-
tored as described above. For all the ligand inhibition experiments,
the time of incubation of TTR with trypsin at 37°C was extended to
96 h. The ThT assay could not be used because mds84 strongly
interferes with the fluorescence measurement. Quantification of the
band of the full-length protomers in SDS–PAGE was performed as
measurement of the susceptibility to proteolysis of TTR as described
above. Experimental data were fitted to nonlinear regression curves
using GraphPad Prism v5. Concentrations of ligand-inhibiting TTR
fibril formation by 50% (IC50) were determined from aggregation
curves and expressed as mean  SD of three independent experi-
ments.
Role of shear and interfacial forces in the cleavage of wild-type
and other amyloidogenic TTR variants
Structural destabilization of wild-type and L55P, V30M and V122I
TTR variants might enable proteolytic cleavage of the protein. We
investigated the role that shear forces (Bekard et al, 2011) and
hydrophobic interactions (Chandler, 2005) might play in this
process under our experimental conditions. To estimate the shear
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forces acting on the TTR tetramers in our system, we applied the
model described by Shankaran & Neelamegham (Shankaran &
Neelamegham, 2004). According to this model, the shear force (Fs)
acting on a molecule can be calculated as:
Fs ¼ a lYR2
where a is the force coefficient, l is the dynamic viscosity and c is
the shear rate (dv/dx). We considered TTR as a dumb-bell-shaped
molecule with each end having a radius R of 3 nm. The value of a
for this molecular geometry is 10 as previously reported (Shan-
karan & Neelamegham, 2004), where the shear rate for our system
is 438 s. Using these parameters, we calculated a shear force Fs
acting on TTR of ~1017 N. This force is about 5 orders of magni-
tudes smaller than the forces required to destabilize the structure
of a protein (Cecconi et al, 2005; Borgia et al, 2008), and thus,
under our experimental conditions, Fs should not play an important
role for TTR fibrillogenesis.
To estimate the hydrophobic interaction forces acting on the
tetramer at the air/water interface (AWI), we calculated the
hydrophobic interaction energy (EHydro) as (Donaldson et al, 2011):
EHydro ¼ 2 Y ða  a0Þ exp ðd=DhydroÞ
where Υ is the interfacial tension, d is the distance between the
tetramer and the AWI, a is the exposed hydrophobicity of the
molecule at distance d, a0 is the exposed hydrophobicity of one
amino acid and Dhydro is the hydrophobic decay length. By taking
the derivative of EHydro with respect to d, the hydrophobic force
(FHydro) acting on the molecule at AWI was calculated as:
FHydro ¼ ðdEHydro=ddÞ ¼ ð2Y ða  a0Þ expðd=DhydroÞÞ=Dhydro
For TTR tetramer, we used Υ = 50 mJ/m2, as employed in a similar
system (Johnson et al, 1971), a0 = 50 A˚
2, Dhydro = 10 A˚ (Israelachvili,
2011) and a(d) = a0 (1 – exp(d/Dhydro))1/2. Considering the
above parameters, we estimated that within 10 A˚ from the AWI, the
hydrophobic forces (FHydro) acting on the molecule vary from 5 to
100 pN.
Expanded View for this article is available online:
http://embomolmed.embopress.org
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